Optalysys technology can be used to perform pattern matching, comparing input data to reference images and identifying similarities or abnormalities.

Genome Analysis


In genomics, pattern matching against a sequence of nucleotides or amino acids is critical to the assembly, annotation and comparison of complex genomes.  This helps tackle diseases in humans, such as cancer and in crops that provide global food security.

The public sequencing databases that contain this data are doubling in size every 18 months or less. Extensive searches of these DNA databases is becoming too expensive and requires access to large High Performance Computing (HPC) resources that consume vast amounts of energy for power and cooling.

How Optalysys technology can help:

Optalysys technology will perform these extensive database searches at speeds that are magnitudes faster than traditional silicon HPC systems and at a fraction of the energy consumption and cost.

This not only makes this technology more accessible and affordable for existing HPC users but also expands the reach to new users where the cost is currently prohibitive e.g. it could eventually lead to a system in every GP surgery for early diagnosis and preventative measures.

MRI Scanner

MRI scanner


MRI scanners are commonly used to profile internal structures of the body in high detail. Currently a sample of the images is analysed by eye for abnormalities after a significant amount of time has been spent scanning a small area of the body.

How Optalysys technology can help:

In conjunction with the manual analysis, Optalysys technology could analyse all of the data collected by the scanners rather than just a sample to identify potential areas that may have been overlooked. This could lead to faster, more comprehensive scanning.

Latest news view all
Optalysys, Ltd. Raises $4 Million Seed Round to Break Bottlenecks in Genomic Research and Big Data Analysis

Light-Speed Optical Processing Startup to Democratize Access to High-Powered Computing and Drive Advances in Research and Development GLASSHOUGHTON, WEST YORKSHIRE, U.K. and RENO, Nev.–September 20, 2017 Optalysys Ltd. (@Optalysys), a start-up pioneering the development of light-speed optical coprocessors, today announced the company raised 3.95 million U.S. dollars / 3.05 million British pounds from undisclosed angel […]

read more
Bio-IT World interviews Earlham Institute and Optalysys on using optical processing for genetic sequence alignment

Bio IT World interviewed the Earlham Institute and Optalysys in an article published on 18th September 2017, on how Optalysys’s optical computing technology is being applied to genetic sequence alignment.  This follows our recent joint press release, demonstration and presentation at the Genome 10k / Genome Science Conference on 29th-31st August 2017.   Click HERE to […]

read more
New video from Optalysys showing demonstration of latest prototype

Optalysys demonstrated its latest prototype at the Genome 10k/Genome Science conference on 29th to 31st August 2017 in Norwich, UK. The video shows the technology housed in a desktop computer performing genomic sequence alignment. At the conference, Optalysys collaboration partner, the Earlham Institute, presented the latest test results on the accuracy of the technology where […]

read more
Optalysys and The Earlham Institute Demonstrate Results of Breakthrough Optical Processing for Sequence Alignment

Prototype Technology to Advance and Democratize High-Performance Genomic Research NORWICH, U.K. – 30 August 2017—Optalysys Ltd. (@Optalysys), a start-up pioneering the development of light-speed optical co-processors, will demonstrate the latest prototype of its breakthrough technology for genomic searching at the Genome 10k / Genome Science conference. Optalysys partner, The Earlham Institute (EI), will present the […]

read more